There’s a reason lots of companies are working on GLP-1-based drugs for obesity: The other stuff tends not to work. The latest biotech to learn

Plus, news about Astellas’ setidegrasib and Anavex: 📈 Kodiak’s eye drug win: The biotech’s experimental drug Zenkuda, whose scientific name is tarcocimab tedromer, beat a

A March study in Nature Medicine showed that AI designed for therapy can deliver better care than human clinicians in a specific type of therapy.

Who knows what’s going to happen to the Advisory Committee on Immunization Practices? Former member Robert Malone suggested in a string of social media posts

A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.